Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Associat
about
Risk Stratification in Differentiated Thyroid Cancer: An Ongoing ProcessA Risk-adapted Approach to Follow-up in Differentiated Thyroid CancerContemporary Management of Recurrent Nodal Disease in Differentiated Thyroid CarcinomaInternal radiation therapy: a neglected aspect of nuclear medicine in the molecular eraManaging newly diagnosed thyroid cancerCurrent status and future perspectives in differentiated thyroid cancerBRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerSERIAL NECK ULTRASOUND IS MORE LIKELY TO IDENTIFY FALSE-POSITIVE ABNORMALITIES THAN CLINICALLY SIGNIFICANT DISEASE IN LOW-RISK PAPILLARY THYROID CANCER PATIENTSRecurrence rate in regional lymph nodes in 737 patients with follicular or Hürthle cell neoplasms.Limited clinical value of periablative changes of serum markers in the prediction of biochemical remission in patients with papillary thyroid cancerDifferentiated Thyroid Cancer-Treatment: State of the Art.New insights in risk stratification of differentiated thyroid cancer.Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara.Identification of Intermediate- to High-Risk Papillary Thyroid Carcinoma Patients Who May Be Safely Managed without the Performance of Delayed Stimulated Thyroglobulin Measurements following Total Thyroidectomy and Radioactive Iodine TherapyRecombinant human thyroid-stimulating hormone-aided remnant ablation achieves a response to treatment comparable to that with thyroid hormone withdrawal in patients with clinically relevant lymph node metastases.Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.Diagnostic accuracy of thyroid nodule growth to predict malignancy in thyroid nodules with benign cytology: systematic review and meta-analysis.Evaluation of Thyroid Bed Nodules on Ultrasonography after Total Thyroidectomy: Risk for Loco-Regional Recurrence of Thyroid Cancer.The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence.Evaluating Positron Emission Tomography Use in Differentiated Thyroid Cancer.Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis.Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatmentIs there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?Role of Recombinant Human Thyrotropin (rhTSH) in the Treatment of Well-Differentiated Thyroid Cancer.Short-term Follow-up US Leads to Higher False-positive Results Without Detection of Structural Recurrences in PTMCFollicular Thyroid Carcinoma: Disease Response Evaluation Using American Thyroid Association Risk Assessment Guidelines.The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.Postoperative stimulated thyroglobulin level and recurrence risk stratification in differentiated thyroid cancer.A Prospective Study Showing an Excellent Response of Patients with Low-Risk Differentiated Thyroid Cancer Who Did Not Undergo Radioiodine Remnant Ablation after Total Thyroidectomy.A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.Cardiac Effects of Thyrotropin Oversuppression with Levothyroxine in Young Women with Differentiated Thyroid Cancer.Combined analysis of circulating epithelial cells and serum thyroglobulin for distinguishing disease status of the patients with papillary thyroid carcinoma.Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence.Cost-effectiveness analysis of papillary thyroid cancer surveillanceExtranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.Effectiveness of routine ultrasonographic surveillance of patients with low-risk papillary carcinoma of the thyroid.Comparison of Thyroglobulin Measurements Using Three Different Immunoassay Kits: A BRAMHS Tg-Plus RIA Kit, a BRAMHS hTg Sensitive Kryptor Kit, and a Beckman Coulter ACCESS Immunoassay Kit.Serum Cytokinome Profile Evaluation: A Tool to Define New Diagnostic and Prognostic Markers of Cancer Using Multiplexed Bead-Based Immunoassays
P2860
Q26765083-2EAE851F-AB96-44A7-A74F-F6F94E3BE7E5Q26765090-3EDF1294-8D3D-4CD8-9E29-C44F08AFAAE3Q26765093-ED970632-0CDE-4F8D-8A3F-56A18BB8D55CQ26786554-5880BADF-C818-448E-B942-A2137A769755Q26825293-8D762D90-99EB-4CB6-869B-ED61A1A05775Q27024484-84451F5E-F8F7-40A2-9DB2-F070B9E9FD21Q28075975-E17A66D3-9E50-4041-BBF7-A7A933FAECE2Q30367068-4AADCE82-B05B-469A-8651-2156F685AF4BQ30374359-8C3D4056-CFC0-467F-AE5E-06870C709C80Q30571649-004C68FD-E61F-49CC-A5B9-943B100F08EAQ33669903-8D18C073-9B58-43A9-9BB8-41DDB36D8C4EQ33839037-A28633E3-829B-4E4A-9019-7BD4F9AB7A55Q33915384-FDFBFA2F-D181-4A01-9F68-78CCB6D0F426Q34153332-05FCD7F5-2612-44A1-AA4E-C3D3D5D5B18CQ35012911-E0FDBFDD-5DCC-44C8-BD1A-82F361AD0F0CQ35029676-77C996A3-4503-4D76-BF9A-6A58F10D1412Q35396089-37323A4E-8743-4952-A880-E8CEAFC573C2Q35840041-2758FF4E-7CBD-4B95-9C44-A9AF4A29603BQ35905439-F468B6D1-E355-49ED-9A8B-B36637E77ED9Q35989876-90FB82F0-0DEF-4649-895B-605067913CD7Q36030298-4E5A3AC2-14DD-46ED-AE61-953DAA05BC35Q36108073-C794F351-3C22-4C91-9815-30D20644EF26Q36124278-FB655787-1E41-42F0-9F70-4BB4D92F1F32Q36233648-CC46C216-1B77-4C4F-8A16-7D4965358805Q36240455-5B047803-6C19-4801-881A-B697BD14B2E1Q36445070-D03547AD-C25C-498A-A893-C643EC0FE2DAQ36472630-FB897905-A0EF-4871-84DE-63ED544EC395Q36666417-F7A02F31-B150-41EB-8B50-28C6393F8FAAQ36801435-94D2D04B-E44B-47BD-96B6-332024BF21D1Q36811424-9B68CE42-F22B-4274-A7EA-8D9D1E05C9A3Q36830210-56C4C009-474C-4A43-A6FF-C75E70E209FBQ37072847-962F368C-BC46-48B2-8660-60CA35319D92Q37086254-3DF94861-4F37-4F83-BB0F-4162817205BDQ37114407-7348312B-3F43-4340-B9C9-F413B328AD6EQ37157764-C9E2BBC3-40CA-4487-BBFC-C3823F50FF95Q37163494-9409E7A9-EC5C-4BAC-B206-B347B51D4CB2Q37178936-68D4AB19-A05B-46B8-B96C-FE47F88F9888Q37190693-E92D1854-357A-44B9-B7B3-25A81D001F1EQ37316042-0316D916-3A27-4F2C-AA96-9F2F86E57CE9Q37516483-0E69DF0A-124B-4A6E-9728-A0E2A724DED4
P2860
Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Associat
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Estimating risk of recurrence ...... new American Thyroid Associat
@en
type
label
Estimating risk of recurrence ...... new American Thyroid Associat
@en
prefLabel
Estimating risk of recurrence ...... new American Thyroid Associat
@en
P2093
P2860
P356
P1433
P1476
Estimating risk of recurrence ...... oid Association staging system
@en
P2093
Ashok Shaha
Hernan Tala
James A Fagin
Matvey Brokhin
Mithat Gonen
R Michael Tuttle
Rebecca Leboeuf
Ronald Ghossein
P2860
P304
P356
10.1089/THY.2010.0178
P50
P577
2010-10-29T00:00:00Z